ribavirin has been researched along with ubiquinone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
David, D; Garcia, C; Guarda, DC; Rubin, J; Rupprecht, CE; Stamler, A; Willoughby, RE; Zohar, Z | 1 |
Frampton, CM; Gane, EJ; Gibson, M; Keogh, GF; Lockhart, MM; Murphy, MP; Orr, DW; Smith, RA; Taylor, KM; Weilert, F | 1 |
1 trial(s) available for ribavirin and ubiquinone
Article | Year |
---|---|
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients.
Topics: Administration, Oral; Adult; Alanine Transaminase; Antioxidants; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Double-Blind Method; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Mitochondria, Liver; Organophosphorus Compounds; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Ubiquinone; Viral Load | 2010 |
1 other study(ies) available for ribavirin and ubiquinone
Article | Year |
---|---|
Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea.
Topics: Amantadine; Anesthetics, Dissociative; Animals; Antiviral Agents; Child, Preschool; Combined Modality Therapy; Dogs; Drug Therapy, Combination; Equatorial Guinea; Fatal Outcome; Humans; Ketamine; Male; Midazolam; Rabies; Rabies virus; Ribavirin; Treatment Outcome; Ubiquinone | 2009 |